Conclusion of CDX process & Directorate changes

Summary by AI BETAClose X

Nanoco Group PLC has concluded its extensive sale process, the CDX Process, as no firm offers were received, and will now focus on investing in existing high-potential business areas while reducing gross monthly cash operating costs to between £300,000 and £400,000. This strategic shift follows operational progress, including a new Joint Development Agreement with a second Asian chemical customer and a three-year extension with its first, alongside the receipt of litigation proceeds from LG Electronics Inc. In connection with these changes, CEO Dmitry Shashkov will depart in February 2026, with Non-Executive Chairman Jalal Bagherli becoming Executive Chairman and CFO Liam Gray taking on the role of Interim CEO. The Non-Executive Board will also be reduced in size, with Dr. Alison Fielding and Dieter May stepping down in April 2026. Nanoco is also initiating proceedings against Shoei Chemical Inc. and Shoei Electronic Materials, Inc. for intellectual property infringement.

Disclaimer*

UK 100

Latest directors dealings